Developing a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation - Rationale, methods and preliminary results from a Sino-American collaboration

Fitoterapia

Volumn 82, Issue 1, 2011, Pages 17-33

  Eisenberg, David M ^a,b   Harris, Eric S J ^a   Littlefield, Bruce A ^a   Cao, Shugeng ^a   Craycroft, Jane A ^a   Scholten, Robert ^a   Bayliss, Peter ^a,c   Fu, Yanling ^d   Wang, Wenquan ^d   Qiao, Yanjiang ^c   Zhao, Zhongzhen ^e   Chen, Hubiao ^e   Liu, Yong ^d   Kaptchuk, Ted ^a,b   Hahn, William C ^c   Wang, Xiaoxing ^c   Roberts, Thomas ^c   Shamu, Caroline E ^a   Clardy, Jon ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Ethnomedicine; Herbal medicine; Library; Traditional Chinese

Indexed keywords

ANGIOSPERM; ARTICLE; ASTERACEAE; BIOLOGICAL ACTIVITY; BOTANY; CHEMISTRY; CHINESE MEDICINE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOCUMENTATION; DRUG CONTAMINATION; DRUG COST; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EMBRYO; ETHNOBOTANY; EXTRACTION; FLOWER; FRACTIONATION; FRUIT; GEOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LEGUME; LIBRARY; MEDICINAL PLANT; NONHUMAN; PLANT BULB; PLANT LEAF; PLANT ROOT; PLANT STEM; PLANT TUBER; POST HOC ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; RHIZOME; ROSACEAE; TRADITIONAL MEDICINE;

CHINA; COOPERATIVE BEHAVIOR; DRUG DISCOVERY; DRUGS, CHINESE HERBAL; HERBAL MEDICINE; HUMANS; LIBRARIES; MATERIA MEDICA; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; PLANTS, MEDICINAL; UNITED STATES;

EID: 79151479223     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.11.017     Document Type: Article

References (61)

1. M. Zedong Mao Zedong's Manuscripts since the Funding of People's Republic of China 1991 The Central Literature Publishing House Beijing, China
2. A.L. Harvey Natural products in drug discovery Drug Discov Today 13 2008 894 901
3. D.J. Newman, G.M. Cragg, and K.M. Snader The influence of natural products upon drug discovery Nat Prod Rep 17 2000 215 234
4. Cragg G.M., Boyd M.R., Cardellina J.H., Newman D.J., Snader K.M., and T.G. McCloud Ethnobotany and drug discovery: the experience of the US National Cancer Institute Ciba Found Symp 185 1994 178 190
5. D.M. Eisenberg, R.C. Kessler, C. Foster, F.E. Norlock, D.R. Calkins, and T.L. Delbanco Unconventional medicine in the United States. Prevalence, costs, and patterns of use N Engl J Med 328 1993 246 252
6. D.M. Eisenberg, R.B. Davis, and S.L. Ettner Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey JAMA 280 1998 1569 1575
7. D.W. Kaufman, J.P. Kelly, L. Rosenberg, T.E. Anderson, and A.A. Mitchell Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey JAMA 287 2002 337 344
8. Barnes P.M., Adams P.F., and Schiller J.S. Summary health statistics for the U.S. population: National Health Interview Survey, 2001 Vital Health Stat 10 2003 1 82
9. P.M. Barnes, B. Bloom, and R.L. Nahin Complementary and alternative medicine use among adults and children: United States Natl Health Stat Report 2008 2007 1 23
10. R.L. Nahin, P.M. Barnes, B.J. Stussman, and B. Bloom Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States Natl Health Stat Report 2009 2007 1 14
11. Li B., Wu S., and Lui C. China pharmaceuticals: investing in Traditional Chinese Medicine (TCM). Hong Kong 2009
12. National Center for Complementary and Alternative Medicine (NCCAM) Centers for Research on Complementary and Alternative Medicine (CRC) Program. CY 2003 Research Priorities. A priority to elucidate mechanisms of action and conduct small, well-developed phase I and II trials. December 2, 2002. (Accessed September 19, Accessed 2010, at http://web.archive.org/web/20021225053952/http: //nccam.nih.gov/research/priorities/indexhtm#2 ).
13. W.K. Oh, P.W. Kantoff, and V. Weinberg Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer J Clin Oncol 22 2004 3705 3712
14. P.M. Wolsko, D.K. Solondz, R.S. Phillips, S.C. Schachter, and D.M. Eisenberg Lack of herbal supplement characterization in published randomized controlled trials Am J Med 118 2005 1087 1093
15. R.B. Turner, R. Bauer, K. Woelkart, T.C. Hulsey, and J.D. Gangemi An evaluation of Echinacea angustifolia in experimental rhinovirus infections N Engl J Med 353 2005 341 348
16. Blumenthal M., and Farnsworth N.R. Echinacea angustifolia in rhinovirus infections N Engl J Med 353 2005 1971 1972 author reply -2.
17. S. Bent, C. Kane, and K. Shinohara Saw palmetto for benign prostatic hyperplasia N Engl J Med 354 2006 557 566
18. DiPaola R.S., and Morton R.A. Proven and unproven therapy for benign prostatic hyperplasia N Engl J Med 354 2006 632 634
19. NCCAM Policy: Natural Product Integrity. (Accessed 10/6/10, at http://nccam.nih.gov/research/policies/naturalproduct.htm.)
20. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 2010 726 732
21. J. Holzbeieriein Hsp90: a drug target? Curr Oncol Rep 12 2010 95 101
22. P. Richardson Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study Br J Haematol 150 2010 438 445
23. M. Suffness, and J. Douros Current status of the NCI plant and animal product program J Nat Prod 45 1982 1 14
24. R. Verpoorte Pharmacognosy in the new millennium: leadfinding and biotechnology J Pharm Pharmacol 52 2000 253 262
25. D.S. Fabricant, and N.R. Farnsworth The value of plants used in traditional medicine for drug discovery Environ Health Perspect 109 Suppl 1 2001 69 75
26. Bensky D., Clavey S., Stoger E., and Gamble A. Chinese Herbal Medicine: Materia Medica 2004 Eastland Press Seattle
27. V. Scheid, Bensky D., Ellis A., and Barolet R. Chinese herbal medicine: Formulas and strategies 2009 Eastland Press Seattle 2nd ed.
28. L. Agrawal, X. Lu, Q. Jin, and G. Alkhatib Anti-HIV therapy: current and future directions Curr Pharm Des 12 2006 2031 2055
29. Borisy A.A., Elliott P.J., Hurst N.W., Lee M.S., Lehar J., E.R. Price, Serbedzija G., Zimmermann G.R., Foley M.A., Stockwell B.R., and Keith C.T. Systematic discovery of multicomponent therapeutics PNAS 100 2003 7977 7982
30. H. Wagner, and G. Ulrich-Merzenich Synergy research: approaching a new generation of phytopharmaceuticals Phytomedicine 16 2009 97 110
31. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. Beijing: People's Medical Publishing House; 2005.
32. Larsen HO, Olsen CS. Unsustainable Collection and Unfair Trade? Uncovering and Assessing Assumptions Regarding Central Himalayan Medicinal Plant Conservation In: Biodiversity and Conservation, 2007, vol. 16 (6), pp. 1679-1697.
33. Convention on International Trade in Endangered Species of Wild Flora and Fauna and Flora (CITES) Appendices I, II and III. (Accessed September 19, 2010, at http://www.cites.org/eng/app/appendices.shtml.)
34. J. Hildreth, E. Hrabeta-Robinson, W. Applequist, J. Betz, and J. Miller Standard operating procedure for the collection and preparation of voucher plant specimens for use in the nutraceutical industry Anal Bioanal Chem 389 2007 13 17
35. Zhao Z.Z., Xiao P.G., Xiao Y., and Yuen J.P.S. Quality assurance of Chinese Herbal Medicines (CHMs) J Food Drug Anal 15 2007 337 346
36. NSF International Standard/American National Standard #173 for Dietary Supplements. Ann Arbor: NSF International; 2008.
37. World Health Organization Operational Guidance: Information needed to support clinical trials of herbal products UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) 2005
38. Harris ESJ, Woolf AD, Eisenberg DM et al. Heavy Metal and Pesticide Content in Commonly Prescribed Individual Raw Chinese Herbal Medicines. In Preparation.
39. Harris ESJ, Erickson SD, Tolopko AN, Cao SG, Craycroft JA, Scholten R, Fu YL, Wang WQ, Liu Y, Zhao ZZ, Clardy J, Shamu C, Eisenberg DM. Traditional Medicine Collection Tracking System (TM-CTS): A Database for Ethnobotanically-Driven Drug-Discovery Programs. In Review.
40. Firestein R., Bass A.J., Kim S.Y., Dunn I.F., Silver S.J., and Guney I. CDK8 is a colorectal cancer oncogene that regulates Β-catenin activity Nature 455 2008 547 551
41. Wu Z.Y. Raven P.H. Flora of China, Multiple Volumes 1994 Missouri Botanical Garden Press St. Louis eds.
42. Delabays N., Simonnet X., and Gaudin M. The genetics of artemisinin content in Artemisia annua L. and the breeding of high yielding cultivars Curr Med Chem 8 2001 1795 1801
43. Goodger J.Q.D., Whincup A.L., Field A.R., Holtum, JAM, and Woodrow I.E. Variation in huperzine A and B in Australasian Huperzia species Biochem Syst Ecol 36 2008 612 618
44. A.M. Viljoen, S. Subramoney, S.F. van Vuuren, K.H. Baser, and B. Demirci The composition, geographical variation and antimicrobial activity of Lippia javanica (Verbenaceae) leaf essential oils J Ethnopharmacol 96 2005 271 277
45. D.Y. Hong, A.J. Lau, and C.L. Yeo Genetic diversity and variation of saponin contents in Panax notoginseng roots from a single farm J Agric Food Chem 53 2005 8460 8467
46. Rehill B.J., Whitham T.G., Martinsen G.D., Schweitzer J.A., Baily J.K., and Lindroth R.L. Developmental trajectories in cottonwood phytochemistry J Chem Ecol 32 2006 2269 2285
47. T. Han, Hu Y., S.Y. Zhou, Li H.L., Zhang Q.Y., Zhang H., Huang B.K., Rahman K., Zheng H.C., and Qin L.P. Correlation between the genetic diversity and variation of total phenolic acids contents in Fructus Xanthii from different populations in China Biomed Chromatogr 22 2008 478 486
48. S. Su, C.M. He, L.C. Li, J.K. Chen, and T.S. Zhou Genetic characterization and phytochemical analysis of wild and cultivated populations of Scutellaria baicalensis Chem Biodivers 5 2008 1353 1363
49. T.T. Dong, X.M. Cui, and Z.H. Song Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents J Agric Food Chem 51 2003 4617 4623
50. X.Q. Ma, Q. Shi, J.A. Duan, T.T. Dong, and K.W. Tsim Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations J Agric Food Chem 50 2002 4861 4866
51. D.M. Ribnicky, A. Poulev, B. Schmidt, W.T. Cefalu, and I. Raskin Evaluation of botanicals for improving human health Am J Clin Nutr 87 2008 472S 475S
52. B.M. Schmidt, D.M. Ribnicky, P.E. Lipsky, and I. Raskin Revisiting the ancient concept of botanical therapeutics Nat Chem Biol 3 2007 360 366
53. M.S. Butler The role of natural product chemistry in drug discovery J Nat Prod 67 2004 2141 2153
54. F. Sams-Dodd Drug discovery: selecting the optimal approach Drug Discov Today 11 2006 465 472
55. B. Blomberg, and B. Fourie Fixed-dose combination drugs for tuberculosis: application in standardised treatment regimens Drugs 63 2003 535 553
56. Schellenberg D., Abdulla S., and Roper C. Current issues for anti-malarial drugs to control P. falciparum malaria Curr Mol Med 6 2006 253 260
57. D.N. Waterhouse, K.A. Gelmon, and R. Klasa Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers Curr Cancer Drug Targets 6 2006 455 489
58. P.C. Deedwania, and N. Volkova Current treatment options for the metabolic syndrome Curr Treat Options Cardiovasc Med 7 2005 61 74
59. T. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
60. UNEP Convention on Biological Diversity. United Nations Environment Programme. (Accessed September 19, 2010, at http://www.cbd.int.)
61. National Center for Complementary and Alternative Medicine. (Accessed at http://nccam.nih.gov/.)